[ Price : $8.95]
FDA warns Vietnams Yahon Enterprise about CGMP violations in its manufacturing of finished drugs.[ Price : $8.95]
Hikma Pharmaceuticals extends a Class 1 recall of one lot of acetaminophen injection, 1,000mg/100mL due to the potential presence ...[ Price : $8.95]
Federal Register notice: FDA extends the comment period on its 6/26-released Information Technology (IT) Strategy and Customer Exp...[ Price : $8.95]
Federal Register notice: FDA announces that OMB has approved an information collection entitled Survey on Quantitative Claims in D...[ Price : $8.95]
Three stakeholders provide requested input to FDA on the risks and benefits of non-device software functions.[ Price : $8.95]
FDA warns Indias Brassica Pharma about CGMP violations in its production of finished drugs at a facility in Thane, India.[ Price : $8.95]
FDA warns Criticare Technologies about QS violations in its manufacturing of patient monitors at a medical device facility in Warw...[ Price : $8.95]
FDA posts answers to frequently asked questions about its new laboratory-developed test final rule.